Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 3
1969 2
1971 1
1972 2
1973 1
1974 1
1976 1
1983 1
1985 1
1987 1
1989 1
1990 1
1992 3
1994 1
1995 2
1996 1
1997 8
1998 3
1999 5
2000 4
2001 6
2002 8
2003 9
2004 8
2005 11
2006 21
2007 12
2008 16
2009 8
2010 29
2011 30
2012 20
2013 22
2014 26
2015 26
2016 36
2017 41
2018 29
2019 25
2020 43
2021 41
2022 56
2023 55
2024 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

626 results

Results by year

Filters applied: . Clear all
Page 1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Among authors: rosenkranz s. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. Eur Heart J. 2022. PMID: 36017548 No abstract available.
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. Among authors: rosenkranz s. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Among authors: rosenkranz s. Eur Respir J. 2023 Jan 6;61(1):2200879. doi: 10.1183/13993003.00879-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36028254 Free article. No abstract available.
Interventional therapies for pulmonary embolism.
Götzinger F, Lauder L, Sharp ASP, Lang IM, Rosenkranz S, Konstantinides S, Edelman ER, Böhm M, Jaber W, Mahfoud F. Götzinger F, et al. Among authors: rosenkranz s. Nat Rev Cardiol. 2023 Oct;20(10):670-684. doi: 10.1038/s41569-023-00876-0. Epub 2023 May 12. Nat Rev Cardiol. 2023. PMID: 37173409 Free PMC article. Review.
Pulmonary Hypertension.
Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S. Hoeper MM, et al. Among authors: rosenkranz s. Dtsch Arztebl Int. 2017 Feb 3;114(5):73-84. doi: 10.3238/arztebl.2017.0073. Dtsch Arztebl Int. 2017. PMID: 28241922 Free PMC article. Review.
Pulmonary hypertension due to left heart disease.
Vachiéry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, Coghlan G, Chazova I, De Marco T. Vachiéry JL, et al. Among authors: rosenkranz s. Eur Respir J. 2019 Jan 24;53(1):1801897. doi: 10.1183/13993003.01897-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545974 Free PMC article. Review.
Pulmonary hypertension.
Bauersachs J, Rosenkranz S. Bauersachs J, et al. Among authors: rosenkranz s. Herz. 2023 Aug;48(4):257-258. doi: 10.1007/s00059-023-05188-0. Epub 2023 Jul 31. Herz. 2023. PMID: 37525084 English. No abstract available.
STING orchestrates the neuronal inflammatory stress response in multiple sclerosis.
Woo MS, Mayer C, Binkle-Ladisch L, Sonner JK, Rosenkranz SC, Shaposhnykov A, Rothammer N, Tsvilovskyy V, Lorenz SM, Raich L, Bal LC, Vieira V, Wagner I, Bauer S, Glatzel M, Conrad M, Merkler D, Freichel M, Friese MA. Woo MS, et al. Among authors: rosenkranz sc. Cell. 2024 Jul 25;187(15):4043-4060.e30. doi: 10.1016/j.cell.2024.05.031. Epub 2024 Jun 14. Cell. 2024. PMID: 38878778 Free article.
Left ventricular heart failure and pulmonary hypertension.
Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Rosenkranz S, et al. Eur Heart J. 2016 Mar 21;37(12):942-54. doi: 10.1093/eurheartj/ehv512. Epub 2015 Oct 27. Eur Heart J. 2016. PMID: 26508169 Free PMC article. Review.
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial.
Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G, Duerschmied D, Empen K, Ferreira M, Girard P, Huisman MV, Jiménez D, Katsahian S, Kozak M, Lankeit M, Meneveau N, Pruszczyk P, Petris A, Righini M, Rosenkranz S, Schellong S, Stefanovic B, Verhamme P, de Wit K, Vicaut E, Zirlik A, Konstantinides SV, Meyer G; PEITHO-3 Investigators. Sanchez O, et al. Among authors: rosenkranz s. Thromb Haemost. 2022 May;122(5):857-866. doi: 10.1055/a-1653-4699. Epub 2021 Oct 31. Thromb Haemost. 2022. PMID: 34560806 Free PMC article. Clinical Trial.
626 results